Health Robotics continues to spearhead the global healthcare industry and persisting on its worldwide quest to provide safe and cost-effective Intravenous Admixture Compounding Automation to hospitals all over the world.
Said Abu Laila, PharmaTech Medical's General Manager, stated: “Health Robotics is the only company in the world that provides hospitals with both Robotics and Non-Robotics' based Intravenous Admixture Compounding Automation solutions for Chemotherapy, TPNs, and other IVs. As the undisputed global leader in the market with 10 times more installations that all of its worldwide competitors[1] combined, we are extremely fortunate to be able to bring Health Robotics' world-leading life-critical medical devices to the GCC.”
Gaspar DeViedma, Health Robotics' Executive Vice President, stated: “i.v.STATION ONCO represents Health Robotics' 2nd Generation Cancer Therapy Compounding robot for syringes and I.V. Bags, several years ahead of its competition1. Amongst the technology innovations pioneered by i.v.STATION ONCO are its: ability to handle pre-attached lines to IV Bags; small footprint [at 15% to 25% of the size/weight of other I.V. Robots]; faster throughput [up to 40 doses per hour instead of 20 doses per hour]; automated tamper-evident syringe capping; and finally, RFID support. Together with i.v.STATION and i.v.SOFT and their extreme price/value advantages over the competition1, we expect to replicate in GCC on long term basis, starting in 2013, our market success.”
Said Abu Laila, PharmaTech Medical's General Manager, stated: “Health Robotics is the only company in the world that provides hospitals with both Robotics and Non-Robotics' based Intravenous Admixture Compounding Automation solutions for Chemotherapy, TPNs, and other IVs. As the undisputed global leader in the market with 10 times more installations that all of its worldwide competitors[1] combined, we are extremely fortunate to be able to bring Health Robotics' world-leading life-critical medical devices to the GCC.”
Gaspar DeViedma, Health Robotics' Executive Vice President, stated: “i.v.STATION ONCO represents Health Robotics' 2nd Generation Cancer Therapy Compounding robot for syringes and I.V. Bags, several years ahead of its competition1. Amongst the technology innovations pioneered by i.v.STATION ONCO are its: ability to handle pre-attached lines to IV Bags; small footprint [at 15% to 25% of the size/weight of other I.V. Robots]; faster throughput [up to 40 doses per hour instead of 20 doses per hour]; automated tamper-evident syringe capping; and finally, RFID support. Together with i.v.STATION and i.v.SOFT and their extreme price/value advantages over the competition1, we expect to replicate in GCC on long term basis, starting in 2013, our market success.”
Companies in this article
![“Another key [UDI] benefit, because we're calling that product by the same name across the healthcare supply chain… rich and robust data that we can access around supply consumption and utilization rates. One of the buzz terms we've heard during the COVID-19 crisis was what's my burn rate? How fast am I going through gowns, masks, gloves?” – Mike Schiller, Senior Director at AHRMM](https://img.healthcarepackaging.com/files/base/pmmi/all/image/2020/08/UDI.5f4d326e41d53.png?auto=format&fit=crop&h=146&w=340)
